Police have been called in to several campuses to arrest demonstrators
Moderna to make milestone payments to NIH for COVID vaccine
Moderna and the US National Institutes of Health had entered into a license agreement related to certain patents concerning the COVID vaccine products
Published : 25 Feb 2023, 09:10 AM
Updated : 25 Feb 2023, 09:10 AM
Moderna Inc will make certain contingent development, commercial and regulatory milestone payments to the US National Institutes of Health (NIH) related to the development of COVID-19 vaccines, the company said in a filing on Friday.
Moderna and the US government agency had entered into a license agreement in December related to certain patents concerning the COVID vaccine products, the filing showed.
The vaccine maker first disclosed the deal in its fourth-quarter earnings release stating it missed profit estimates hurt by the royalty payment to NIH.
Moderna said under the agreement it would pay low single-digit royalties on future net sales and also minimum annual royalties.
RELATED STORIES
Students blame universities for failing to protect their right to protest or stand up for human rights
There have been a spate of major demonstrations on college campuses from California to Massachusetts over the past week
The contaminant has been linked to the deaths of more than 300 children in Africa and Asia
